Identification of an episignature for CHD3-related Snijders Blok-Campeau syndrome reveals heterogeneity in the CHARGE syndrome episignature: towards a better characterisation of chromatinopathies
Abstract Background Recent advances in sequencing technologies have enhanced patient diagnosis; however, causal pathogenic variants remain unidentified for a significant number of patients due to limited understanding of certain variants, regulatory sequences, or sequencing challenges, such as compl...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2026-04-01
|
| Seria: | Genome Medicine |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s13073-026-01639-5 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
